Decisions about add-on reimbursement for medical devices in France in October 2018

29

Nov 2018

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in October 2018.

Seven (7) decisions were released for prostheses:

  • ODRA, custom-made, articulated, dynamic orthosis using ODRA (Distraction Orthotic and Rotation for Osteoarthritis) (renewal of registration, approved)
  • LEGION OXINIUM, biocondylar femoral implant, cemented, made of zirconium oxide (application for registration, rejected because the data does not demonstrate interest for it)
  • RHEO KNEE (3rd generation), monoaxial knee, microprocessor-controlled joint and magnetorheological fluid (application for registration, approved)
  • PINNACLE ULTAMET, femoral head metal for a total hip prosthesis (cancelled)
  • AMOENA, external silicone breast prosthesis, the standard model (application for the amendment of the registration conditions, approved)
  • NATRELLE 168 / NATRELLE 468, breast implants (cancelled)
  • RL, femoral stem with the modular neck (without cement) (application for registration, rejected because the data does not demonstrate interest for it)

Three (3) decisions were released for cardiovascular devices:

  • CARBONART AVP-BOVIN, aortic duct with a mechanical valve (cancelled)
  • COREVALVE EVOLUT R, aortic valve bioprosthesis implanted by the transcutaneous arterial route (application for registration, approved)
  • COREVALVE EVOLUT PRO, aortic valve bioprosthesis implanted by the transcutaneous arterial route (application for registration, approved)

Eleven (11) decisions were released for other devices:

  • URGOCLEAN, compress and wick (renewal of registration, approved)
  • NEUROCYBERNETIC PROTHESIS (NCP) SYSTEMS 102 & 102R, Neuro-Cybernetic Prothesis Left Wave Nerve Stimulator (NCP) and Bipolar VNS Electrode (cancelled)
  • PHOENIX, viro-inactivated bone allograft, (application for the amendment of the registration conditions, approved)
  • EDEN, lubricated male condom (application for registration, approved)
  • SENTRY 1200, category 3 support mattress for the prevention of pressure pain with automatic, constant pressure and / or dynamic air pressure over 15 cm of air thickness (cancelled)
  • PROVOX LUNA, a respiratory prosthesis for total laryngectomees with or without phonatory implant (application for registration, rejected)
  • KIT BIFLEX, multitype compression system (application for registration, approved)
  • NEOVIS TOTAL multi, sterile emulsion for topical ophthalmic use (application for registration, approved)
  • NEOVIS TOTAL, sterile emulsion for topical ophthalmic use (application for registration, approved)
  • HYLOVIS LIPO, sterile emulsion for topical ophthalmic use (application for registration, approved)
  • HYLOVIS LIPO MULTI, sterile emulsion for topical ophthalmic use (application for registration, approved)

See the list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more

08

Mar 2022

At the end of February 2022, the Dental and Pharmaceutical Benefits Agency (TLV) has launched a theme survey on products for monitoring and diagnostics of sepsis to identify products that may be relevant for health economic assessments at TLV. The suggestions for the products of interest, ongoing clinical studies, or innovation projects could be received until 23 March 2022.

Read more

07

Mar 2022

On February 08, 2022, the Reimbursement Commission of the Social Security Institution released an updated version of the Healthcare Implementation Communique. The main changes relate to the increase in reimbursement fees of services and medical devices by approximately 35-75%.

Read more